Elmira College nursing students test crisis skills in Meningitis simulation on campus
ELMIRA, N.Y. (WETM) – Elmira College senior nursing students took part in an annual public health emergency response exercise on Wednesday morning.
The exercise simulated a Meningitis outbreak on campus. It was held from 10 a.m. to noon in Meier Hall and was designed to give students hands-on experience in managing a public health crisis.
WATCH: Gov. Kathy Hochul gives update on state's measles response
The simulation included faculty, campus security, and community volunteers, who all played roles to make the scenario as realistic as possible.
Meningitis is a highly contagious infection, it affects the fluid and membranes surrounding the brain and spinal cord, according to the Mayo Clinic. There are two types of Meningitis, viral and bacterial, the Mayo Clinic said viral infections are the most common cause of meningitis in the United States.
Students were responsible for assessing symptoms, coordinating care, and working under pressure — just as they would in a real outbreak.
According to Debby Woglom, Nursing faculty at Elmira College, the volunteer patients first checked in at a registration table, then they were sent to a dispensing table where they could get mock antibiotics and talk to an expert if needed.
'We created an outbreak of Meningitis on campus, and they had to do a case investigation like the Public Health Department would do,' Woglom said. 'Then they had to figure out who was exposed to Meningitis, and then they had to dispense medications, so that those who were exposed wouldn't actually get sick,' she said.
Low-cost vaccine & microchip clinic to be held in Knoxville
To prevent confusion, the college sent out alerts in advance to remind students and the public that this was only a drill.
Despite the alerts, the higher level of activity, people moving in and out of Meier Hall, and volunteers playing the role of patients made the exercise feel very realistic, according to nursing student Jamie Wagner.
'It shows you the command you have to go through, just like you would in a job. It shows you who you need to report to, the information that you need to share,' Wagner said. 'Exactly what you need to do to help the public and not become a mass casualty,' she said.
It's important to note, this was just a simulation and there are no known cases of Meningitis at Elmira College.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
5 hours ago
- Medscape
Study Shows Safety of Pharma-Grade CBD for Myocarditis
An oral formulation of pharmaceutically manufactured cannabidiol (CBD) that targets inflammatory pathways in myocarditis and pericarditis has been shown to be as safe as placebo in not elevating cardiovascular risks, results of a prospective trial have shown. The placebo-controlled trial enrolled 89 people with a history of cardiovascular disease (CVD) and/or at least one major risk factor for the condition who had been hospitalized for noncritical COVID-19. Leslie Cooper Jr, MD 'There are 45 or so who received pharmacologically produced CBD who had no increase in overall or cardiovascular adverse events, and in particular there was no prolongation of the QT interval,' Leslie Cooper Jr, MD, chair of cardiovascular medicine at Mayo Clinic Florida in Jacksonville, Florida, told Medscape Medical News . Cooper presented a poster on the study at Heart Failure Association of the European Society of Cardiology (HFA-ESC) 2025. The findings confirmed the safety of CBD doses up to 7.5 mg/kg twice daily used in the ARCHER trial in myocarditis and the MAVERIC trial in pericarditis, Cooper said. Study Shows Safety Signal The researchers designed the study during the COVID-19 pandemic to evaluate if people hospitalized for noncritical COVID-19 with a history of or a risk factor for CVD were also at an increased risk for cardiac inflammation, Cooper said. The study was stopped early because the pandemic ended. 'The findings were underpowered for efficacy, but they did support a safety signal,' he said. The study found no significant differences in adverse events between the CBD and no-CBD groups. For example, the rate of gastrointestinal disorders was 22.2% in the CBD group and 20.5% in the placebo group. Nervous system disorders were observed in 17.8% of CBD patients vs 18.2% of placebo patients. Eleven percent of CBD patients had respiratory, thoracic, and mediastinal disorders compared with 9% of placebo patients. The rates of cardiac adverse events were also similar between the two groups. No patients in the CBD group vs three (6.8%) of those in the placebo group had tachycardia. One case of atrial fibrillation, cardiac failure, left ventricular hypertrophy, and pericardial effusion was observed in the CBD group vs none in the placebo group. One patient in the placebo group vs none in the CBD group had atrial flutter. Most cases of myocarditis are mild and resolve spontaneously without long-term consequences, Cooper said. However, about 25% of cases have significant cardiovascular sequelae, including arrhythmias and heart failure. 'We know, based on clinical grounds, how to identify those complex patients who are probably going to have a rocky long-term course,' he said. New Treatments Needed While one drug, rilonacept (Arcalyst), has been approved for the treatment of recurrent pericarditis, no approved drugs for myocarditis exist. New treatments are also needed for cardiomyopathy. Bettina Heidecker, MD, head of Heart Failure and Cardiomyopathy at the German Charité Heart Center in Berlin, Germany, told Medscape Medical News , said current therapies such as corticosteroids and other immunosuppressants carry long-term risks such as osteoporosis, metabolic disorders, infections, and organ toxicity, 'A pharmaceutically standardized CBD formulation could offer a targeted anti-inflammatory approach with a more favorable side effect profile,' Heidecker told Medscape Medical News . 'This would be particularly beneficial for younger or lower-risk patients, or those in whom prolonged immunosuppression is problematic.' Heidecker said the new data provide a rationale for continued investigation of CBD in myocarditis and pericarditis. 'It will be exciting to investigate how individual patients respond to CBD, particularly early in the treatment course,' she said. Heidecker and her team in Berlin have been studying the utility of noninvasive magnetocardiography to detect myocardial inflammation and monitor response to anti-inflammatory therapy with the hope that the approach 'may help identify early responders and guide personalized treatment strategies with CBD.' The trial was funded by Cardiol Therapeutics. Cooper is a consultant to Cardiol Therapeutics. Heidecker holds patents for RNA-based diagnostics in myocarditis and holds pending patents on magnetocardiography for diagnosing cardiomyopathy. She reported financial relationships with Biomagnetik Park Hoilding, Pfizer, and AstraZeneca.
Yahoo
9 hours ago
- Yahoo
Gov. Hochul's review now pending on Medical Aid in Dying Act
ROCHESTER, N.Y. (WROC) – The New York State Senate has passed the Medical Aid in Dying Act for the first time since the legislation was introduced in 2016. The bill allows terminally ill adults with incurable diseases and six months or less to live the ability to make the decision to peacefully end their lives through a prescription. If signed by Gov. Kathy Hochul, New York State will join 11 other U.S. states in legalizing the end-of-life option. News 8 heard from those in support of and against the legislation, as it now goes to the governor's desk for signature. Andrea Calloway serves as executive director for the Sunset House, which is Irondequoit's only comfort care home for terminally ill patients. The Sunset House has been offering end-of-life care, supported by donations, for over 35 years. 'Here at the Sunset House, we allow the resident to be in control of decision making, as long as it's safe. I believe, personally, people should have the right to their own decisions of what will work best for them,' said Calloway. New York State Assemblymember Josh Jensen has opposed the bill from the beginning and led the debate on the state Assembly floor before it passed. 'What was really prevalent in the Assembly debate is it's not a partisan issue and not a conservative issue, it's a question of morality. It's a question of life or death. I think that was shown not just through opposition of people like me, but I think 21 Democratic no votes and six Democratic no votes in the Senate last night. Certainly, there was bipartisan opposition, but not bipartisan support,' said Asm. Jensen. From the perspective of hospice care, Calloway adds it's unclear what the future of this option might look like for providers like the Sunset House, should it become law. 'It's a jigsaw puzzle of a thousand pieces. There's a lot of moving parts here. There's family involved, friends involved, a doctor involved, and the individual person involved. [It's a question of,] 'Do you have everything in order before you make this decision to do this?' There's lots of pieces involved,' said Calloway. Assemblymember Harry Bronson also weighed in, saying the bill offers a 'compassionate choice.' 'While I understand and respect the concerns of those who object, I believe the Medical Aid in Dying Act is fundamentally about offering a compassionate choice to qualified patients who wish to die on their own terms. This legislation represents a careful balance between providing end-of-life autonomy and maintaining essential protections to ensure that this profound decision is made voluntarily by those who are truly facing the end of their lives.' As the legislation goes before Gov. Hochul for review, the president of the New York State Bar Association issued the following statement to encourage her approval: 'Medical Aid in Dying offers both dignity and compassion to those experiencing a terminal illness. It ensures that New Yorkers have a full array of end-of-life options and provides them with the autonomy to make their own choices to avoid needless suffering. We commend the legislature for passing this important bill and will continue to offer our support and advocacy in encouraging the governor to sign it into law.' More information about the Sunset House and ways to support their care can be found here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
13 hours ago
- Yahoo
New York set to allow physician-assisted death for terminally ill patients
New York lawmakers on Monday passed a bill that would allow terminally ill adults to end their lives with doctor-prescribed lethal medication. The State Senate approved the measure with a 35-27 vote, following the state Assembly's approval in April. If signed into law by Gov. Kathy Hochul, New York would join 11 other states that permit 'medical assistance in dying' (MAiD) or 'assisted suicide' for terminally ill patients, joining Oregon, Colorado, California, Vermont and other jurisdictions where MAiD has been legalized. New York is the second state to approve such legislation in 2025, following Delaware, which did so in May. The bill permits people diagnosed with a terminal illness and a prognosis of six months or less to request a prescription for life-ending medication. To qualify, patients must be at least 18 years old, mentally competent, and have their diagnosis and prognosis confirmed by two physicians. A psychiatric evaluation is required only if deemed necessary by one of the physicians. Supporters of the bill argue that it provides terminally ill individuals with autonomy and a dignified end-of-life option. 'Since the first day that I began advocating for the MAiD Act, I have made it clear that this legislation is about honoring a terminally ill person's choice to make their own end-of-life decisions,' Staten Island Sen. Jessica Scarcella-Spanton told the Advance/ 'This is about giving people the compassion and dignity that they deserve, the importance of which I have witnessed firsthand while meeting with many of the advocates for this legislation, many of whom were or are suffering from a terminal illness.' State Sen. Brad Hoylman-Sigal, a Democrat and the bill's sponsor, echoed that sentiment: 'It's not about hastening death, but ending suffering,' he said, per ABC News. Opponents of the bill, which include the American Medical Association, express concerns about potential abuse, the adequacy of safeguards, and the potential impact on people who lack access to adequate care. 'This is not compassionate care. It is a policy that exploits fear, undermines trust in the medical profession, and opens the door to abuse and neglect,' members of The New York Alliance Against Assisted Suicide said in a statement after the vote. Efforts to legalize medical aid in dying in New York date back more than a decade, but previous attempts through the courts were unsuccessful. The state's Supreme Court rejected a challenge in the 1990s, and in 2017, the New York Court of Appeals ruled that there is no constitutional right to physician-assisted death, leaving the matter to the legislature. Faith groups speak up Since the passage of the bill by the New York Senate, faith groups and religious leaders spoke up condemning the vote. Rabbi Moshe Hauer, executive vice president of the Orthodox Union, the largest umbrella organization of Orthodox Jews, called the vote a 'tragic development for all New Yorkers and a radical departure from the ethical assumptions shared by all faiths.' 'New Yorkers do not need assisted suicide; they need a whole-of society effort to provide 'Medical and Social Aid in Living,' to build hope and enhance care and treatment for the terminally ill and for the physically, emotionally and economically vulnerable, young and old,' Hauer said in a statement. The government must improve care and treatment for the terminally ill, he said. 'Instead, the government is leading the way in validating, accepting, and accelerating despair.' A Catholic group representing bishops of the state also criticized the vote. 'This is a dark day for New York state,' said a statement from Dennis Proust and The New York State Catholic Conference posted on X. The group called on the state to strengthen palliative care, health care and counseling services. 'Passage of the legislation also would send the message — perhaps unintentionally — that suicide is an acceptable solution to a problem," said Robert Bellafiore, the group's spokesman, per National Catholic Reporter. Cardinal Timothy Dolan, the archbishop of New York, had described the proposal as 'a disaster waiting to happen" after the Assembly vote last month. Opponents argue that the legislation would hurt the vulnerable populations, especially those with disabilities and mental illness. The American Medical Association also expressed its opposition to MAiD. 'Physician-assisted suicide is fundamentally incompatible with the physician's role as healer, would be difficult or impossible to control, and would pose serious societal risks,' according to American Medical Association's website. Dr. Lydia Dugdale, a physician and ethicist at Columbia University, argued that MAiD fails to protect people living with depression, a condition that can distort thinking and lead to suicidal decisions that don't reflect a person's true will. Modeled after the Oregon bill, the New York bill, if enacted, will not require patients to be screened for depression. 'This is a major oversight that fails to protect depressed people from making flawed decisions,' Dugdale wrote in a recent New York Times op-ed. 'Depression is not just a mood; it distorts perception, often convincing people that their lives are worthless, their loved ones are better off without them and death is their only option.' Groups opposing MAiD are calling on Hochul to refuse to sign bill. 'We strongly urge her to veto this legislation,' said a statement by The New York Alliance Against Assisted Suicide. 'The governor still has the opportunity to uphold New York's commitment to suicide prevention, protect vulnerable communities, and affirm that every life — regardless of disability, age, or diagnosis — is worthy of care, dignity, and protection." Hochul, a Democrat and a Catholic, has not yet said whether she will sign the bill. The New York Times reported that a spokesperson only said she would review it.
